HSPH1 and melanoma: Previous studies have shown that HSP105 is closely related to melanoma, and evidence from mouse models has shown that the HSP105 DNA vaccine can induce activation of CD4+ T cells and CD8+ T cells, which play important roles in antitumor immunity [6].